India's Pharmaceutical Exports

Country Profile

Laos

Laos is a developing market for Indian pharmaceuticals — $14.4M in FY 2025–26, with 9.4× growth over the past decade. Medicines accounts for 64% of shipments, with vaccines contributing $2.31M. The compound annual growth rate since FY2016 stands at 25.1%.

🇱🇦 $14.4M · 9.4× growth since FY2016 · 25.1% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$14.4M
Exports FY2025–26 DGCIS
9.4×
Growth FY2016→2026
25.1%
CAGR FY2016→2026
64%
Medicines Share
5
Product Categories Supplied
Laos is a developing market for Indian pharmaceuticals — $14.4M in FY 2025–26, with 9.4× growth over the past decade. Medicines accounts for 64% of shipments, with vaccines contributing $2.31M. The compound annual growth rate since FY2016 stands at 25.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $9.22M (64.1%) Medicine Ingredients $2.76M (19.2%) Vaccines $2.31M (16.0%) Traditional & Herbal $92K (0.6%) Surgical & Hospital Supplies $7K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Laos in the RBI overseas direct investment dataset (2011–2026).